Company Overview and News

0
Boracay business operators say lack of permits due to red tape

2018-06-05 newsinfo.inquirer.net
BORACAY ISLAND, Aklan — Several business operators here have described as inaccurate a government report stating that less than 5 percent of businesses on the island were compliant with government permits, claiming many of them had not been issued certain permits or certificates due to red tape.
BB

1
Cello pens maker moves high court against former promoters

2018-04-08 livemint
Mumbai: The maker of Cello pens has moved the Bombay high court against the company’s previous owners allegedly violating a no-compete agreement and venturing into the stationery business.
BB 526586 WIMPLAST

0
Senate bill seeks to create council to manage Boracay

2018-03-26 newsinfo.inquirer.net
A foreign tourist helps pick up trash at a section of a beach on Boracay Island. (File photo by LYN RILLON / Philippine Daily Inquirer)
BB

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to EPA:BB / BIC on message board site Silicon Investor.

BB: BlackBerry (fka RIMM: Research in Motion) BMY (bristol myers squibb)
Hot Tubbers Anonymous Undervalued - OTC/BB Stocks
Nintendo (BB:NTDOY) Great Time To Jump In! NWL: Newell Rubbermaid, Inc.
The Epic American Credit and Bond Bubble Laboratory Post Grubbers Trophy Case
DIGITCOM (DGIV-OTC-bb)Information Thread OTC:BB STOCK PICKING Challenge